{
  "id": 1488,
  "text": "In the second one1464, patients were randomized to receive cisplatin with concurrent EBRT, followed by brachytherapy or gemcitabine with the same radiation therapy.Although it was observed more frequent complete pathological response in the study arm (gemcitabine) than in the control arm $9 6 \\%$ versus $8 8 \\%$ ), no difference in terms of DFS or OS was reported between the two treatment groups.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: In the second one1464, patients were randomized to receive cisplatin with concurrent EBRT, followed by brachytherapy or gemcitabine with the same radiation therapy.Although it was observed more frequent complete pathological response in the study arm (gemcitabine) than in the control arm $9 6 \\%$ versus $8 8 \\%$ ), no difference in terms of DFS or OS was reported between the two treatment groups.\n\n<question>: ",
  "ChatGPT_response_0": "根据研究结果显示，在治疗方案中使用紫杉烷相较于顺铂表现出更频繁的完全病理学反应，研究显示研究组（使用紫杉烷）的完全病理学反应比对照组（使用顺铂）高出约8个百分点。值得注意的是，尽管在完全病理学反应方面有所不同，但在DFS（无疾病生存）或OS（总生存率）方面，两种治疗组之间并没有报告出现差异。",
  "query": "在研究中，哪种治疗方案（紫杉烷或顺铂）表现出更频繁的完全病理学反应？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在研究中，哪种治疗方案（紫杉烷或顺铂）表现出更频繁的完全病理学反应？\n\n<reference text>: In the second one1464, patients were randomized to receive cisplatin with concurrent EBRT, followed by brachytherapy or gemcitabine with the same radiation therapy.Although it was observed more frequent complete pathological response in the study arm (gemcitabine) than in the control arm $9 6 \\%$ versus $8 8 \\%$ ), no difference in terms of DFS or OS was reported between the two treatment groups.\n\n<reply>: ",
  "response": "根据研究结果显示，在治疗方案中使用紫杉烷相较于顺铂表现出更频繁的完全病理学反应，研究显示研究组（使用紫杉烷）的完全病理学反应比对照组（使用顺铂）高出约8个百分点。值得注意的是，尽管在完全病理学反应方面有所不同，但在DFS（无疾病生存）或OS（总生存率）方面，两种治疗组之间并没有报告出现差异。"
}